Clinical Trial Update: Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide mai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2022-05-06